Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

For the first time, conjugated monoclonal antibodies have been added to a list of drugs that pose an occupational hazard. The new cancer treatment targets tumors with deadly toxins – but also can produce some residue that could put health care workers at risk, safety experts caution.

NIOSH: Beware of new targeted cancer drugs

Repeated exposures can add up to a significant hazard